Follow the 툴젠 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 툴젠 has published 8 public disclosures. Market capitalisation: €354.4bn. The latest transaction was reported on 1 September 2026 (Purchase). Among the most active insiders: 제넥신. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
툴젠 es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en el desarrollo de tecnologías de edición genómica.